Sustained Response at Month 12 for Transgene's TG 4001 in HPV-Induced Precancerous Lesions of the Cervix and Next Clinical Development Steps
13th Nov 2006, 22:41 GMT
Transgene SA announces updated data of the completed Phase II trial and development plans going forward for TG 4001, Transgene's therapeutic HPV vaccine for treating precancerous lesions of the cervix.
Sustained Response at Month 12 for Transgene's TG 4001 in HPV-Induced Precancerous Lesions of the Cervix and Next Clinical Development Steps related news:
- Sustained Response at Month 12 for Transgene's TG 4001 in HPV-Induced Precancerous Lesions of the Cervix and Next Clinical Development Steps — PR Newswire: All Releases
- Volume 194, number 12: Human Papillomavirus Prevalence in Women Who Have and Have Not Undergone Hysterectomies — J Infect Dis Latest Issue
- Celebrex for treatment of precancerous cervical changes — The Cancer Blog
- 'Muscle' Protein Drives Prostate Cancer — Health News from Medical News Today
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years — EurekAlert! - Medicine and Health
- Data from Pre-Clinical Study of Protalex's PRTX-100 Compound Presented at the 5th Int'l Conference on Autoimmunity in Sorrento, Italy — Bio-Technology News from StratCenter.com
- Alexza Reports Q3 Financial Results and Updates Status of Development Pipeline — StratWire - Business of Healthcare NewsFeed
- Overweight in Celiac Disease: Prevalence, Clinical Characteristics, and Effect of a Gluten-Free Diet — Medscape Headlines
- Most women unaware about HPV — MSNBC.com: Health
- The CDC Releases Its HPV Vaccine Recommendations — Medscape Med Students Headlines
Latest news from Surgery News from StratCenter.com:
- Technology Making LASIK Safer for Those Who Have Had Previous Eye Surgery
- Symbion to Participate in Credit Suisse Phoenix Healthcare Conference
- Experts: Laser Eye Surgery Safe
- Survey Says: Women Love Botox Almost as Much as Paris
- Cardiogenesis Reports Q3 2006 Results
- SOLX Establishes Int'l Certification Program
- Encision Secures $2 mln Line of Credit Facility
- South Broward Hospital District Board Approves Purchase Agreement for Hollywood Med Cntr
- Beyond Bifocals: Data Shows Wavefront Technology Benefits Patients With Presbyopia
- New Study Finds VitalStim Therapy More Effective Than Traditional Dysphagia Treatment